Edition:
United Kingdom

Bellicum Pharmaceuticals Inc (BLCM.OQ)

BLCM.OQ on NASDAQ Stock Exchange Global Market

8.50USD
2:56pm GMT
Change (% chg)

$0.01 (+0.12%)
Prev Close
$8.49
Open
$8.56
Day's High
$8.66
Day's Low
$8.50
Volume
14,508
Avg. Vol
157,539
52-wk High
$15.51
52-wk Low
$7.42

Select another date:

Tue, Nov 7 2017

BRIEF-Bellicum reports qtrly earnings per share loss‍ $0.71​

* Bellicum Pharmaceuticals Inc qtrly earnings per share loss‍ $0.71​

BRIEF-Bellicum Pharmaceuticals enters a cancer research grant contract with cancer prevention and research institute of Texas

* Bellicum Pharmaceuticals says ‍on Aug. 9, entered a cancer research grant contract with cancer prevention and research institute of Texas

BRIEF-Bellicum Pharmaceuticals qtrly loss per share $0.74

* Bellicum pharmaceuticals reports second quarter 2017 financial results and provides corporate update

BRIEF-Bellicum Pharmaceuticals files for mixed shelf offering of upto $150 mln

* Bellicum Pharmaceuticals Inc files for mixed shelf offering of upto $150 million - sec filing Source text: (http://bit.ly/2tmwwmp) Further company coverage:

BRIEF-Bellicum Pharmaceuticals files prospectus relating to disposition of up to about 5 million shares

* Bellicum Pharmaceuticals files prospectus relating to disposition of up to about 5 million shares of co's common stock held by the selling stockholders

Select another date: